BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12937244)

  • 1. Respiratory syncytial virus pneumonitis complicating immunosuppressive treatment for ANCA-positive vasculitis.
    Jones R; Shah S; MacMahon EE; Goldsmith DJ
    Nephrol Dial Transplant; 2003 Sep; 18(9):1920-2. PubMed ID: 12937244
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.
    Booth AD; Almond MK; Burns A; Ellis P; Gaskin G; Neild GH; Plaisance M; Pusey CD; Jayne DR;
    Am J Kidney Dis; 2003 Apr; 41(4):776-84. PubMed ID: 12666064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mizoribine induces remission of relapsed ANCA-associated renal vasculitis.
    Nishioka Y; Horita Y; Tadokoro M; Taura K; Suyama N; Miyazaki M; Harada T; Kohno S
    Nephrol Dial Transplant; 2006 Apr; 21(4):1087-8. PubMed ID: 16326748
    [No Abstract]   [Full Text] [Related]  

  • 4. ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients.
    Harper L; Savage CO
    Rheumatology (Oxford); 2005 Apr; 44(4):495-501. PubMed ID: 15613403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasculitis and infection: effects of immunosuppressive therapy.
    Lode HM; Schmidt-Ioanas M
    Clin Nephrol; 2005 Dec; 64(6):475-9. PubMed ID: 16370163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
    Hu W; Liu C; Xie H; Chen H; Liu Z; Li L
    Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhodococcus equi infection during treatment of a c-ANCA positive vasculitis: a case report.
    Garthwaite EA; Border DJ; Jones CH; Worth DP
    Rheumatol Int; 2007 Jan; 27(3):285-7. PubMed ID: 17013608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancytopenia in ANCA associated vasculitis: response to immunosuppressive therapy.
    Letellier E; Cunningham J; Feakins RM; Hughes GR; D'Cruz DP
    Clin Exp Rheumatol; 2003; 21(3):415-6. PubMed ID: 12846080
    [No Abstract]   [Full Text] [Related]  

  • 9. Opportunistic infections are preceded by a rapid fall in antineutrophil cytoplasmic antibody (ANCA) titer in patients with ANCA associated vasculitis.
    Palsson R; Choi HK; Niles JL
    J Rheumatol; 2002 Mar; 29(3):505-10. PubMed ID: 11908563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vasculitis attacking the kidneys].
    Grönhagen-Riska C; Teppo AM
    Duodecim; 1995; 111(15):1442-51. PubMed ID: 9244700
    [No Abstract]   [Full Text] [Related]  

  • 11. Vasculitis syndromes: which maintenance therapy for ANCA vasculitis?
    Nachman PH
    Nat Rev Nephrol; 2009 May; 5(5):254-6. PubMed ID: 19384325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineutrophil cytoplasmic antibody vasculitis associated with mycobacterium avium intracellulare infection.
    Chaiamnuay S; Heck LW
    J Rheumatol; 2005 Aug; 32(8):1610-2. PubMed ID: 16078343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case report of steroid-resistant antineutrophil cytoplasmic antibody-related vasculitis successfully treated by mizoribine in a hemodialysis patient.
    Tokunaga M; Tamura M; Kabashima N; Serino R; Shibata T; Matsumoto M; Miyamoto T; Miyazaki M; Furuno Y; Fujimatsu S; Muta T; Takeuchi M; Abe H; Okazaki M; Otsuji Y
    Ther Apher Dial; 2009 Feb; 13(1):77-9. PubMed ID: 19379174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based treatment of systemic vasculitis.
    Jayne D
    Rheumatology (Oxford); 2000 Jun; 39(6):585-95. PubMed ID: 10888702
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment on Ibernon et al. Clin Nephrol 2008; 69: 395-401.
    Stassen PM; Tervaert JW; Stegeman CA
    Clin Nephrol; 2008 Sep; 70(3):270. PubMed ID: 18793573
    [No Abstract]   [Full Text] [Related]  

  • 16. When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy?
    Flossmann O; de Groot K
    Nat Clin Pract Nephrol; 2007 May; 3(5):236-7. PubMed ID: 17457358
    [No Abstract]   [Full Text] [Related]  

  • 17. Infections and vasculitis.
    Thomas K; Vassilopoulos D
    Curr Opin Rheumatol; 2017 Jan; 29(1):17-23. PubMed ID: 27662570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis (CYCLOPS study)].
    Kötter I
    Z Rheumatol; 2009 Sep; 68(7):575-7. PubMed ID: 19652987
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of ANCA-positive vasculitis with thyroid disease.
    Rothe HM; Siegmund J; Müller H; Wopperer J
    Nephrol Dial Transplant; 2008 Jun; 23(6):2107; author reply 2107-8. PubMed ID: 18323519
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytokines and adhesion molecules in renal vasculitis and lupus nephritis.
    Tesar V; Masek Z; Rychlík I; Merta M; Bartůnková J; Stejskalová A; Zabka J; Janatková I; Fuciková T; Dostál C; Becvár R
    Nephrol Dial Transplant; 1998 Jul; 13(7):1662-7. PubMed ID: 9681708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.